富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/12/11 | 日証協 | 108,700株 | -9.27% | 128,730株 | +24.22% | 262,371株 | +4.13% | 35,602株 | -67.87% |
2020/12/04 | 日証協 | 119,800株 | +25.97% | 103,631株 | +80.23% | 251,969株 | +45.93% | 110,800株 | +628.95% |
2020/11/27 | 日証協 | 95,100株 | -7.76% | 57,500株 | -39.09% | 172,669株 | -5.78% | 15,200株 | -50.49% |
2020/11/20 | 日証協 | 103,100株 | +38.39% | 94,400株 | +88.8% | 183,269株 | +11.03% | 30,700株 | +65.05% |
2020/11/13 | 日証協 | 74,500株 | -40.3% | 50,000株 | -45.7% | 165,069株 | -27.02% | 18,600株 | -27.91% |
2020/11/06 | 日証協 | 124,800株 | +1.05% | 92,080株 | -20.74% | 226,169株 | +3.05% | 25,800株 | -4.44% |
2020/10/30 | 日証協 | 123,504株 | +42.12% | 116,174株 | +28.02% | 219,469株 | +4.67% | 27,000株 | -18.18% |
2020/10/23 | 日証協 | 86,900株 | +3.63% | 90,749株 | -11.2% | 209,669株 | +6.96% | 33,000株 | -17.3% |
2020/10/16 | 日証協 | 83,854株 | +56.29% | 102,200株 | +102.63% | 196,023株 | +23.5% | 39,901株 | -15.28% |
2020/10/09 | 日証協 | 53,654株 | +0.48% | 50,437株 | -22.76% | 158,718株 | -12.54% | 47,100株 | -48.43% |
2020/10/02 | 日証協 | 53,400株 | -22.63% | 65,300株 | +100.92% | 181,466株 | -4.08% | 91,330株 | +39.86% |
2020/09/25 | 日証協 | 69,019株 | -5.97% | 32,500株 | -55.41% | 189,185株 | +11.49% | 65,300株 | +44.47% |
2020/09/18 | 日証協 | 73,400株 | -36.56% | 72,885株 | -8.44% | 169,685株 | -78.51% | 45,200株 | -93.23% |
2020/09/11 | 日証協 | 115,700株 | +17.94% | 79,600株 | +975.68% | 789,485株 | +390.3% | 667,363株 | +6326.22% |
2020/09/04 | 日証協 | 98,100株 | +1.66% | 7,400株 | -79.61% | 161,022株 | +4.74% | 10,385株 | +29.81% |
2020/08/28 | 日証協 | 96,500株 | -15.72% | 36,300株 | +79.7% | 153,737株 | -5.59% | 8,000株 | -29.82% |
2020/08/21 | 日証協 | 114,500株 | -7.81% | 20,200株 | +48.53% | 162,837株 | -5.89% | 11,400株 | +67.65% |
2020/08/14 | 日証協 | 124,200株 | +2.05% | 13,600株 | -58.41% | 173,037株 | -0.75% | 6,800株 | -26.88% |
2020/08/07 | 日証協 | 121,700株 | +15.68% | 32,700株 | +37.39% | 174,337株 | +3.32% | 9,300株 | -21.85% |
※株式分割は考慮していませんのでご注意ください。
Page Top